Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 17, 2025 09:00 ET | Source: Transparency Market Research

Peptide API Market Set for Explosive Growth, projected to Reach US$ 94.2 Billion by 2034, Fueled by Rising Chronic Disease Incidence and Technological Innovation | Latest Report by TMR

Wilmington, Delaware, Transparency Market Research Inc. –, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The peptide API market has shown promising growth in recent years, reaching a valuation of US$ 9.2...
October 03, 2024 08:30 ET | Source: Mangoceuticals, Inc.

MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions

Dallas, Texas, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness...
July 17, 2024 07:43 ET | Source: Research and Markets

Global GLP-1 Receptor Agonist (Ozempic, Rybelsus, Trulicity, Saxenda, Wegovy, Victoza, Mounjaro, Zepbound) Market Analysis Report 2024-2030 Featuring Eli Lilly and C, Sanofi, Novo Nordisk, AstraZeneca

Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Global GLP-1 Receptor Agonist Market Size, Share & Trends Analysis Report by Product (Trulicity, Wegovy, Ozempic, Mounjaro), Application (Type 2...
January 29, 2024 10:48 ET | Source: Research and Markets

GLP-1 Receptor Agonist Market on the Rise with Anticipated Surge to $16.82 Billion by 2028

Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "GLP-1 Receptor Agonist Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global market for GLP-1 receptor...
August 29, 2018 09:00 ET | Source: ProLynx LLC

ProLynx and Daiichi Sankyo announce the development of technology for half-life extension of small molecules in the eye

SAN FRANCISCO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- ProLynx and Daiichi Sankyo Company, Limited, announced today the publication of a paper in the journal TVST entitled “A controlled release system for...
April 03, 2018 09:00 ET | Source: ProLynx LLC

ProLynx extends lead in half-life extension platform technology – Shows primary deuterium kinetic isotope effects prolong drug release and polymer biodegradation in a drug delivery system

SAN FRANCISCO, April 03, 2018 (GLOBE NEWSWIRE) -- ProLynx announced today the publication of a paper demonstrating its leading capabilities to exploit primary deuterium kinetic isotope effects...
September 25, 2017 09:00 ET | Source: ProLynx LLC

ProLynx announces SBIR grant award to develop novel technology for dual receptor agonists

SAN FRANCISCO, Sept. 25, 2017 (GLOBE NEWSWIRE) -- Today, ProLynx announced it was awarded a Small Business Innovation Research (SBIR) grant from the NIH to expand its technology platform to control...